CD274 and cutaneous melanoma: PD1 checkpoint blockade in metastatic UM is less efficacious than in cutaneous melanoma likely due to differences in biology, including differences in PD-L1 and immune checkpoint molecule expression, and low mutational burden compared to cutaneous melanoma (14).